Future & research

Future and research

Where AI in breast cancer is heading: clinical trials, biomarkers, wearables, explainable systems — and the frontier questions being explored today.

Frontiernext — multimodal AI and virtual biopsies6topics

Future and research

Where AI in breast cancer is heading: clinical trials, biomarkers, wearables, explainable systems — and the frontier questions being explored today.

Explore this section

AI in clinical trials

AI speeds up trials — recruiting patients faster, reading images consistently and predicting outcomes earlier.

AI and biomarkers

AI links imaging patterns to molecular biology, revealing non-invasive “imaging biomarkers” that guide decisions without extra biopsies.

Wearables and continuous monitoring

Wearables track health signals over time, building a continuous picture of well-being that complements one-off clinic visits.

Explainable AI

A “black box” AI is hard to trust; explainable AI shows its reasoning, letting doctors understand why a case was flagged.

Data quality and ethics

AI learns from data — the quality, consent and governance of that data therefore decide whether AI is safe, fair and ethical.

Research frontiers

From digital twins to multimodal models, the next wave of AI research promises deeper, more holistic care.

Explore the AI knowledge base

Six connected domains, each with its articles, evidence and practical advice — designed as a journey, not a single page.

Back to the AI hub